{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:38:55Z","timestamp":1790876335034,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.brachy.2016.06.012","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T16:08:34Z","timestamp":1469722114000},"page":"554-561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Trends in the utilization of adjuvant vaginal brachytherapy in women with early-stage endometrial carcinoma: Results of an updated period analysis of SEER data"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8418-5545","authenticated-orcid":false,"given":"Ankit","family":"Modh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed I.","family":"Ghanem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Burmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabila","family":"Rasool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Elshaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2016.06.012_bib1","first-page":"5","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.brachy.2016.06.012_bib2","series-title":"National Comprehensive Cancer Network, NCCN Clinical Practice Guidelines in Oncology: Uterine Neoplasms","year":"2015"},{"key":"10.1016\/j.brachy.2016.06.012_bib3","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2016.06.012_bib4","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2016.06.012_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","article-title":"Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis","volume":"373","author":"ASTEC EN.5 Study Group","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2016.06.012_bib6","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2016.06.012_bib7","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ijrobp.2015.08.023","article-title":"Long-term impact of endometrial cancer diagnosis and treatment on health-related quality of life and cancer survivorship: results from the randomized PORTEC-2 trial","volume":"93","author":"de Boer","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.06.012_bib8","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.ijrobp.2005.04.038","article-title":"American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy","volume":"63","author":"Small","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.06.012_bib9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijrobp.2011.05.052","article-title":"Trends in the utilization of adjuvant vaginal cuff brachytherapy and\/or external beam radiation treatment in stage I and II endometrial cancer: a surveillance, epidemiology, and end-results study","volume":"83","author":"Patel","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.06.012_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.brachy.2015.09.012","article-title":"Vaginal brachytherapy for postoperative endometrial cancer: 2014 survey of the American Brachytherapy Society","volume":"15","author":"Harkenrider","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2016.06.012_bib11","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/cncr.22185","article-title":"Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients","volume":"107","author":"Chan","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2016.06.012_bib12","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(09)62002-X","article-title":"Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis","volume":"375","author":"Todo","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2016.06.012_bib13","series-title":"SEER*Stat Database: Incidence\u2014SEER 9 Regs Research Data, Nov 2014 Sub (1973-2012) <Katrina\/Rita Population Adjustment> - Linked to County Attributes - Total U.S., 1969-2013 Counties","year":"2015"},{"key":"10.1016\/j.brachy.2016.06.012_bib14","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.ijrobp.2011.04.014","article-title":"External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma\u2013a prospective randomized study","volume":"82","author":"Sorbe","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.06.012_bib15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/IGC.0000000000000589","article-title":"Survey of current practice patterns in the treatment of early-stage endometrial cancer","volume":"26","author":"Pereira","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2016.06.012_bib16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","article-title":"Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study","volume":"373","author":"ASTEC Study Group","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2016.06.012_bib17","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","article-title":"Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial","volume":"100","author":"Benedetti Panici","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.brachy.2016.06.012_bib18","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/jnci\/djt279","article-title":"Cause-specific effects of radiotherapy and lymphadenectomy in stage I\u2013II endometrial cancer: a population-based study","volume":"105","author":"Mell","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.brachy.2016.06.012_bib19","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/sj.bjc.6603012","article-title":"Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers","volume":"94","author":"Hamilton","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.brachy.2016.06.012_bib20","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ygyno.2013.01.025","article-title":"A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium","volume":"129","author":"Jhingran","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2016.06.012_bib21","series-title":"Pelvic radiation therapy or vaginal implant radiation therapy, paclitaxel, and carboplatin in treating patients with high-risk stage I or stage II endometrial cancer","year":"2016"},{"key":"10.1016\/j.brachy.2016.06.012_bib22","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","article-title":"The National Cancer Data Base: a powerful initiative to improve cancer care in the United States","volume":"15","author":"Bilimoria","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.brachy.2016.06.012_bib23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ygyno.2011.06.036","article-title":"Hysterectomy for uterine adenocarcinoma in the elderly: tumor characteristics, and long-term outcome","volume":"123","author":"Gayar","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2016.06.012_bib24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.brachy.2016.06.012_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.prro.2014.01.003","article-title":"The role of postoperative radiation therapy for endometrial cancer: executive summary of an American Society for Radiation Oncology evidence-based guideline","volume":"4","author":"Klopp","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.brachy.2016.06.012_bib26","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.ijrobp.2013.03.016","article-title":"Muddy water? Variation in reporting receipt of breast cancer radiation therapy by population-based tumor registries","volume":"86","author":"Walker","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.06.012_bib27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ijrobp.2013.10.032","article-title":"Trends in the utilization of brachytherapy in cervical cancer in the United States. In regard to Han et\u00a0al","volume":"88","author":"Smith","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.06.012_bib28","unstructured":"Creutzberg, C. PORTEC-4 trial website. Available at: www.msbi.nl\/portec4. Accessed June 14,\u00a02016."}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472116305037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472116305037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:10:23Z","timestamp":1761531023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472116305037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S1538472116305037"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2016.06.012","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in the utilization of adjuvant vaginal brachytherapy in women with early-stage endometrial carcinoma: Results of an updated period analysis of SEER data","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2016.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}